Cedelizumab Biosimilar Monoclonal Antibody (CD4) for Research

Cat No.: GMP-Bios-INN-773

Anti-CD4 therapeutic antibody (Pre-made Cedelizumab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Cedelizumab is a monoclonal antibody acting on the immune system.[1] Possible indications include the prevention of organ transplant rejections and the treatment of autoimmune diseases.[2]

Order Information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. →
Catalog No. Package Price(In USD)
GMP-Bios-INN-773-1mg 1mg 618
GMP-Bios-INN-773-10mg 10mg
GMP-Bios-INN-773-100mg 100mg
GMP-Bios-INN-773-xmg ≥100mg



Product Details

Products Name (INN Index) Pre-Made Cedelizumab Biosimilar, Whole Mab, Anti-Cd4 Antibody: Anti-IMD79/OKT4D therapeutic antibody
INN Name Cedelizumab
TargetCD4
FormatWhole mAb
DerivationHumanized
Species Reactivityhuman
CH1 IsotypeIgG4 - kappa
VD LCIgG4 - kappa
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesCentocor Ortho Biotech Products LP (Raritan NJ USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development Tech0



About target - CD4

1. Protein Tumor necrosis factor receptor superfamily member 13C

2. Gene CD4

3. Organism Homo sapiens (Human)

Function
Integral membrane glycoprotein that plays an essential role in the immune response and serves multiple functions in responses against both external and internal offenses. In T-cells, functions primarily as a coreceptor for MHC class II molecule:peptide complex. The antigens presented by class II peptides are derived from extracellular proteins while class I peptides are derived from cytosolic proteins. Interacts simultaneously with the T-cell receptor (TCR) and the MHC class II presented by antigen presenting cells (APCs). In turn, recruits the Src kinase LCK to the vicinity of the TCR-CD3 complex. LCK then initiates different intracellular signaling pathways by phosphorylating various substrates ultimately leading to lymphokine production, motility, adhesion and activation of T-helper cells. In other cells such as macrophages or NK cells, plays a role in differentiation/activation, cytokine expression and cell migration in a TCR/LCK-independent pathway. Participates in the development of T-helper cells in the thymus and triggers the differentiation of monocytes into functional mature macrophages.

(Microbial infection) Primary receptor for human immunodeficiency virus-1 (HIV-1) (PubMed:2214026, PubMed:16331979, PubMed:9641677, PubMed:12089508).

Down-regulated by HIV-1 Vpu (PubMed:17346169).

Acts as a receptor for Human Herpes virus 7/HHV-7 (PubMed:7909607).